12712501 7966152 1360025 8005752 9276018 9502105 1361580 15380931 25680364 8097539 14711314 14754373 9111295 10797229 19715279 9786179 7608905 10893307 - Search Results

Year	Number of Results
1992	2
1993	1
1994	2
1995	1
1997	2
1998	2
1999	1
2000	1
2003	1
2004	3
2009	1
2015	1
2022	0

1

Structure-activity relationships of dynorphin analogs substituted in positions 2 and 3.

Schlechtingen G, DeHaven RN, Daubert JD, Cassel J, Goodman M. Schlechtingen G, et al. Biopolymers. 2003;71(1):71-6. doi: 10.1002/bip.10382. Biopolymers. 2003. PMID: 12712501

2

Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.

Meyer JP, Collins N, Lung FD, Davis P, Zalewska T, Porreca F, Yamamura HI, Hruby VJ. Meyer JP, et al. J Med Chem. 1994 Nov 11;37(23):3910-7. doi: 10.1021/jm00049a010. J Med Chem. 1994. PMID: 7966152

3

Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.

Snyder KR, Story SC, Heidt ME, Murray TF, DeLander GE, Aldrich JV. Snyder KR, et al. J Med Chem. 1992 Nov 13;35(23):4330-3. doi: 10.1021/jm00101a010. J Med Chem. 1992. PMID: 1360025

4

Side-product formation during cyclization with HBTU on a solid support.

Story SC, Aldrich JV. Story SC, et al. Int J Pept Protein Res. 1994 Mar;43(3):292-6. doi: 10.1111/j.1399-3011.1994.tb00393.x. Int J Pept Protein Res. 1994. PMID: 8005752

5

Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.

Choi H, Murray TF, DeLander GE, Schmidt WK, Aldrich JV. Choi H, et al. J Med Chem. 1997 Aug 15;40(17):2733-9. doi: 10.1021/jm960747t. J Med Chem. 1997. PMID: 9276018

6

Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.

Guerrini R, Capasso A, Marastoni M, Bryant SD, Cooper PS, Lazarus LH, Temussi PA, Salvadori S. Guerrini R, et al. Bioorg Med Chem. 1998 Jan;6(1):57-62. doi: 10.1016/s0968-0896(97)10008-6. Bioorg Med Chem. 1998. PMID: 9502105

7

N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.

Choi H, Murray TF, DeLander GE, Caldwell V, Aldrich JV. Choi H, et al. J Med Chem. 1992 Nov 27;35(24):4638-9. doi: 10.1021/jm00102a019. J Med Chem. 1992. PMID: 1361580 No abstract available.

8

Pharmacological and functional biochemical properties of D-Ala2-D-Nle5-enkephalin-Arg-Phe.

Tóth F, Horváth G, Szikszay M, Farkas J, Tóth G, Borsodi A, Benyhe S. Tóth F, et al. Regul Pept. 2004 Oct 15;122(2):139-46. doi: 10.1016/j.regpep.2004.06.017. Regul Pept. 2004. PMID: 15380931

9

Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.

Bird MF, Vardanyan RS, Hruby VJ, Calò G, Guerrini R, Salvadori S, Trapella C, McDonald J, Rowbotham DJ, Lambert DG. Bird MF, et al. Br J Anaesth. 2015 Apr;114(4):646-56. doi: 10.1093/bja/aeu454. Epub 2015 Feb 13. Br J Anaesth. 2015. PMID: 25680364 Free PMC article.

10

Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.

Snyder KR, Murray TF, DeLander GE, Aldrich JV. Snyder KR, et al. J Med Chem. 1993 Apr 16;36(8):1100-3. doi: 10.1021/jm00060a018. J Med Chem. 1993. PMID: 8097539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results